scholarly journals Relation between anthropometric measures of fat distribution and cardiovascular risk factors in overweight pre- and postmenopausal women

1997 ◽  
Vol 66 (4) ◽  
pp. 829-836 ◽  
Author(s):  
A C Perry ◽  
E B Applegate ◽  
M L Allison ◽  
P C Miller ◽  
J F Signorile
Keyword(s):  
Risk Factors ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Postmenopausal Women ◽  
Fat Distribution ◽  
Anthropometric Measures

Abstract #604: Detection of Cardiovascular Risk Factors by Anthropometric Measures in Adults Living in an Urban Setting in Sri Lanka

2015 ◽  
Vol 21 ◽  
pp. 114-115
Author(s):  
Kavinga Gunawardane ◽  
Noel Somasundaram ◽  
Neil Thalagala ◽  
Pubudu Chulasiri ◽  
Sudath Fernando
Keyword(s):  
Risk Factors ◽  
Cardiovascular Risk ◽  
Sri Lanka ◽  
Cardiovascular Risk Factors ◽  
Urban Setting ◽  
Anthropometric Measures

scholarly journals Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study

2006 ◽  
Vol 154 (1) ◽  
pp. 131-139 ◽  
Author(s):  
Lenora M Camarate S M Leão ◽  
Mônica Peres C Duarte ◽  
Dalva Margareth B Silva ◽  
Paulo Roberto V Bahia ◽  
Cláudia Medina Coeli ◽  
...  
Keyword(s):  
Risk Factors ◽  
Insulin Resistance ◽  
Blood Pressure ◽  
Cardiovascular Disease ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Postmenopausal Women ◽  
Fat Mass ◽  
Visceral Fat ◽  
Increased Risk

Background: There has been a growing interest in treating postmenopausal women with androgens. However, hyperandrogenemia in females has been associated with increased risk of cardiovascular disease. Objective: We aimed to assess the effects of androgen replacement on cardiovascular risk factors. Design: Thirty-seven postmenopausal women aged 42–62 years that had undergone hysterectomy were prospectively enrolled in a double-blind protocol to receive, for 12 months, percutaneous estradiol (E2) (1 mg/day) combined with either methyltestosterone (MT) (1.25 mg/day) or placebo. Methods: Along with treatment, we evaluated serum E2, testosterone, sex hormone-binding globulin (SHBG), free androgen index, lipids, fibrinogen, and C-reactive protein; glucose tolerance; insulin resistance; blood pressure; body-mass index; and visceral and subcutaneous abdominal fat mass as assessed by computed tomography. Results: A significant reduction in SHBG (P < 0.001) and increase in free testosterone index (P < 0.05; Repeated measures analysis of variance) were seen in the MT group. Total cholesterol, triglycerides, fibrinogen, and systolic and diastolic blood pressure were significantly lowered to a similar extent by both regimens, but high-density lipoprotein cholesterol decreased only in the androgen group. MT-treated women showed a modest rise in body weight and gained visceral fat mass relative to the other group (P < 0.05), but there were no significant detrimental effects on fasting insulin levels and insulin resistance. Conclusion: This study suggests that the combination of low-dose oral MT and percutaneous E2, for 1 year, does not result in expressive increase of cardiovascular risk factors. This regimen can be recommended for symptomatic postmenopausal women, although it seems prudent to perform baseline and follow-up lipid profile and assessment of body composition, especially in those at high risk of cardiovascular disease.

scholarly journals Effects of high-intensity training on cardiovascular risk factors in premenopausal and postmenopausal women

2017 ◽  
Vol 216 (4) ◽  
pp. 384.e1-384.e11 ◽  
Author(s):  
Camilla M. Mandrup ◽  
Jon Egelund ◽  
Michael Nyberg ◽  
Martina H. Lundberg Slingsby ◽  
Caroline B. Andersen ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Postmenopausal Women ◽  
High Intensity ◽  
High Intensity Training ◽  
Intensity Training

scholarly journals Whole-diet interventions and cardiovascular risk factors in postmenopausal women: A systematic review of controlled clinical trials

Maturitas ◽  
2021 ◽  
Author(s):  
Mojgan Amiri ◽  
Irma Karabegović ◽  
Anniek C. van Westing ◽  
Auke J.C.F Verkaar ◽  
Sara Beigrezaei ◽  
...  
Keyword(s):  
Risk Factors ◽  
Systematic Review ◽  
Clinical Trials ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Postmenopausal Women ◽  
Controlled Clinical Trials

scholarly journals Endothelial Function and Insulin Resistance in Early Postmenopausal Women with Cardiovascular Risk Factors: Importance of ESR1 and NOS3 Polymorphisms

PLoS ONE ◽  
2014 ◽  
Vol 9 (7) ◽  
pp. e103444 ◽  
Author(s):  
Ruth Clapauch ◽  
André Felipe Mourão ◽  
Anete S. Mecenas ◽  
Priscila A. Maranhão ◽  
Ana Rossini ◽  
...  
Keyword(s):  
Risk Factors ◽  
Insulin Resistance ◽  
Cardiovascular Risk ◽  
Endothelial Function ◽  
Cardiovascular Risk Factors ◽  
Postmenopausal Women ◽  
Early Postmenopausal Women

scholarly journals The 60- and 70-kDa heat-shock proteins and their correlation with cardiovascular risk factors in postmenopausal women with metabolic syndrome

2013 ◽  
Vol 19 (4) ◽  
pp. 559-568 ◽  
Author(s):  
Eliana A. P. Nahas ◽  
Jorge Nahas-Neto ◽  
Claudio L. Orsatti ◽  
Ana Paula Tardivo ◽  
Gilberto Uemura ◽  
...  
Keyword(s):  
Risk Factors ◽  
Metabolic Syndrome ◽  
Cardiovascular Risk ◽  
Heat Shock ◽  
Heat Shock Proteins ◽  
Cardiovascular Risk Factors ◽  
Postmenopausal Women ◽  
Shock Proteins
Sign in / Sign up

Export Citation Format

Share Document